HEADER TRANSFERASE 04-FEB-20 6LVM TITLE CRYSTAL STRUCTURE OF FGFR3 IN COMPLEX WITH PYRIMIDINE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FGFR-3; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR3, JTK4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, SIGNALING PROTEIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.ECHIZEN,Y.TATEISHI,Y.AMANO REVDAT 3 29-NOV-23 6LVM 1 REMARK REVDAT 2 29-APR-20 6LVM 1 JRNL REVDAT 1 08-APR-20 6LVM 0 JRNL AUTH I.KURIWAKI,M.KAMEDA,H.HISAMICHI,S.KIKUCHI,K.IIKUBO, JRNL AUTH 2 Y.KAWAMOTO,H.MORITOMO,Y.KONDOH,Y.AMANO,Y.TATEISHI,Y.ECHIZEN, JRNL AUTH 3 Y.IWAI,A.NODA,H.TOMIYAMA,T.SUZUKI,M.HIRANO JRNL TITL STRUCTURE-BASED DRUG DESIGN OF 1,3,5-TRIAZINE AND PYRIMIDINE JRNL TITL 2 DERIVATIVES AS NOVEL FGFR3 INHIBITORS WITH HIGH SELECTIVITY JRNL TITL 3 OVER VEGFR2. JRNL REF BIOORG.MED.CHEM. V. 28 15453 2020 JRNL REFN ESSN 1464-3391 JRNL PMID 32278710 JRNL DOI 10.1016/J.BMC.2020.115453 REMARK 2 REMARK 2 RESOLUTION. 2.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0253 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 10205 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 520 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.53 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.59 REMARK 3 REFLECTION IN BIN (WORKING SET) : 680 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.55 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 35 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2296 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.43000 REMARK 3 B22 (A**2) : 2.34000 REMARK 3 B33 (A**2) : 1.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.70000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.996 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.347 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.270 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.568 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2405 ; 0.005 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3258 ; 1.603 ; 1.699 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 286 ; 7.726 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 114 ;34.686 ;22.193 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 416 ;20.315 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;18.215 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 293 ; 0.115 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1908 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6LVM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1300015569. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NE3A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10740 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.530 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3B2T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CITRIC ACID, PEG 8000, PH 5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.61250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 447 REMARK 465 SER A 448 REMARK 465 HIS A 449 REMARK 465 MET A 450 REMARK 465 LEU A 451 REMARK 465 ALA A 452 REMARK 465 GLY A 453 REMARK 465 VAL A 454 REMARK 465 SER A 455 REMARK 465 GLU A 456 REMARK 465 TYR A 457 REMARK 465 GLU A 458 REMARK 465 LEU A 459 REMARK 465 PHE A 579 REMARK 465 ASP A 580 REMARK 465 THR A 581 REMARK 465 CYS A 582 REMARK 465 LYS A 583 REMARK 465 PRO A 584 REMARK 465 PRO A 585 REMARK 465 GLU A 586 REMARK 465 SER A 756 REMARK 465 THR A 757 REMARK 465 ASP A 758 REMARK 465 GLU A 759 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 498 NH1 NH2 REMARK 470 GLU A 587 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O1P PTR A 577 OD2 ASP A 635 2555 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 462 80.84 -150.66 REMARK 500 LYS A 496 107.36 -48.99 REMARK 500 ASP A 497 -82.12 145.82 REMARK 500 ALA A 499 -44.91 153.55 REMARK 500 MET A 531 -71.61 -59.33 REMARK 500 PRO A 573 -97.22 -62.21 REMARK 500 GLN A 588 -164.64 -62.92 REMARK 500 ASP A 617 36.41 -145.28 REMARK 500 ASP A 635 74.35 67.67 REMARK 500 ASP A 646 12.19 82.26 REMARK 500 THR A 651 -16.90 64.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 574 LEU A 575 131.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EVR A 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6LVK RELATED DB: PDB REMARK 900 RELATED ID: 6LVL RELATED DB: PDB DBREF 6LVM A 472 759 UNP P22607 FGFR3_HUMAN 472 759 SEQADV 6LVM GLY A 447 UNP P22607 EXPRESSION TAG SEQADV 6LVM SER A 448 UNP P22607 EXPRESSION TAG SEQADV 6LVM HIS A 449 UNP P22607 EXPRESSION TAG SEQADV 6LVM MET A 450 UNP P22607 EXPRESSION TAG SEQADV 6LVM LEU A 451 UNP P22607 EXPRESSION TAG SEQADV 6LVM ALA A 452 UNP P22607 EXPRESSION TAG SEQADV 6LVM GLY A 453 UNP P22607 EXPRESSION TAG SEQADV 6LVM VAL A 454 UNP P22607 EXPRESSION TAG SEQADV 6LVM SER A 455 UNP P22607 EXPRESSION TAG SEQADV 6LVM GLU A 456 UNP P22607 EXPRESSION TAG SEQADV 6LVM TYR A 457 UNP P22607 EXPRESSION TAG SEQADV 6LVM GLU A 458 UNP P22607 EXPRESSION TAG SEQADV 6LVM LEU A 459 UNP P22607 EXPRESSION TAG SEQADV 6LVM PRO A 460 UNP P22607 EXPRESSION TAG SEQADV 6LVM GLU A 461 UNP P22607 EXPRESSION TAG SEQADV 6LVM ASP A 462 UNP P22607 EXPRESSION TAG SEQADV 6LVM PRO A 463 UNP P22607 EXPRESSION TAG SEQADV 6LVM LYS A 464 UNP P22607 EXPRESSION TAG SEQADV 6LVM TRP A 465 UNP P22607 EXPRESSION TAG SEQADV 6LVM GLU A 466 UNP P22607 EXPRESSION TAG SEQADV 6LVM PHE A 467 UNP P22607 EXPRESSION TAG SEQADV 6LVM PRO A 468 UNP P22607 EXPRESSION TAG SEQADV 6LVM ARG A 469 UNP P22607 EXPRESSION TAG SEQADV 6LVM ASP A 470 UNP P22607 EXPRESSION TAG SEQADV 6LVM LYS A 471 UNP P22607 EXPRESSION TAG SEQRES 1 A 313 GLY SER HIS MET LEU ALA GLY VAL SER GLU TYR GLU LEU SEQRES 2 A 313 PRO GLU ASP PRO LYS TRP GLU PHE PRO ARG ASP LYS LEU SEQRES 3 A 313 THR LEU GLY LYS PRO LEU GLY GLU GLY CYS PHE GLY GLN SEQRES 4 A 313 VAL VAL MET ALA GLU ALA ILE GLY ILE ASP LYS ASP ARG SEQRES 5 A 313 ALA ALA LYS PRO VAL THR VAL ALA VAL LYS MET LEU LYS SEQRES 6 A 313 ASP ASP ALA THR ASP LYS ASP LEU SER ASP LEU VAL SER SEQRES 7 A 313 GLU MET GLU MET MET LYS MET ILE GLY LYS HIS LYS ASN SEQRES 8 A 313 ILE ILE ASN LEU LEU GLY ALA CYS THR GLN GLY GLY PRO SEQRES 9 A 313 LEU TYR VAL LEU VAL GLU TYR ALA ALA LYS GLY ASN LEU SEQRES 10 A 313 ARG GLU PHE LEU ARG ALA ARG ARG PRO PRO GLY LEU ASP SEQRES 11 A 313 PTR SER PHE ASP THR CYS LYS PRO PRO GLU GLU GLN LEU SEQRES 12 A 313 THR PHE LYS ASP LEU VAL SER CYS ALA TYR GLN VAL ALA SEQRES 13 A 313 ARG GLY MET GLU TYR LEU ALA SER GLN LYS CYS ILE HIS SEQRES 14 A 313 ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL THR GLU ASP SEQRES 15 A 313 ASN VAL MET LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP SEQRES 16 A 313 VAL HIS ASN LEU ASP PTR PTR LYS LYS THR THR ASN GLY SEQRES 17 A 313 ARG LEU PRO VAL LYS TRP MET ALA PRO GLU ALA LEU PHE SEQRES 18 A 313 ASP ARG VAL TYR THR HIS GLN SER ASP VAL TRP SER PHE SEQRES 19 A 313 GLY VAL LEU LEU TRP GLU ILE PHE THR LEU GLY GLY SER SEQRES 20 A 313 PRO TYR PRO GLY ILE PRO VAL GLU GLU LEU PHE LYS LEU SEQRES 21 A 313 LEU LYS GLU GLY HIS ARG MET ASP LYS PRO ALA ASN CYS SEQRES 22 A 313 THR HIS ASP LEU TYR MET ILE MET ARG GLU CYS TRP HIS SEQRES 23 A 313 ALA ALA PRO SER GLN ARG PRO THR PHE LYS GLN LEU VAL SEQRES 24 A 313 GLU ASP LEU ASP ARG VAL LEU THR VAL THR SER THR ASP SEQRES 25 A 313 GLU MODRES 6LVM PTR A 577 TYR MODIFIED RESIDUE MODRES 6LVM PTR A 647 TYR MODIFIED RESIDUE MODRES 6LVM PTR A 648 TYR MODIFIED RESIDUE HET PTR A 577 16 HET PTR A 647 16 HET PTR A 648 16 HET EVR A 801 53 HETNAM PTR O-PHOSPHOTYROSINE HETNAM EVR 2-[[5-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-2-[[3-METHOXY-4- HETNAM 2 EVR [4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1- HETNAM 3 EVR YL]PHENYL]AMINO]PYRIMIDIN-4-YL]AMINO]-N-ETHYL- HETNAM 4 EVR BENZENESULFONAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 3(C9 H12 N O6 P) FORMUL 2 EVR C39 H52 N8 O5 S FORMUL 3 HOH *31(H2 O) HELIX 1 AA1 PRO A 468 ASP A 470 5 3 HELIX 2 AA2 THR A 515 GLY A 533 1 19 HELIX 3 AA3 ASN A 562 ARG A 570 1 9 HELIX 4 AA4 THR A 590 GLN A 611 1 22 HELIX 5 AA5 ALA A 619 ARG A 621 5 3 HELIX 6 AA6 PRO A 657 MET A 661 5 5 HELIX 7 AA7 ALA A 662 ARG A 669 1 8 HELIX 8 AA8 THR A 672 THR A 689 1 18 HELIX 9 AA9 PRO A 699 GLU A 709 1 11 HELIX 10 AB1 THR A 720 TRP A 731 1 12 HELIX 11 AB2 ALA A 734 ARG A 738 5 5 HELIX 12 AB3 THR A 740 THR A 755 1 16 SHEET 1 AA1 5 LEU A 472 GLU A 480 0 SHEET 2 AA1 5 GLN A 485 ILE A 492 -1 O MET A 488 N LYS A 476 SHEET 3 AA1 5 PRO A 502 MET A 509 -1 O VAL A 507 N VAL A 487 SHEET 4 AA1 5 TYR A 552 GLU A 556 -1 O VAL A 555 N ALA A 506 SHEET 5 AA1 5 LEU A 541 CYS A 545 -1 N GLY A 543 O LEU A 554 SHEET 1 AA2 2 CYS A 613 ILE A 614 0 SHEET 2 AA2 2 ARG A 640 ASP A 641 -1 O ARG A 640 N ILE A 614 SHEET 1 AA3 2 VAL A 623 VAL A 625 0 SHEET 2 AA3 2 MET A 631 ILE A 633 -1 O LYS A 632 N LEU A 624 SHEET 1 AA4 2 PTR A 648 LYS A 649 0 SHEET 2 AA4 2 VAL A 670 TYR A 671 -1 O TYR A 671 N PTR A 648 LINK C ASP A 576 N PTR A 577 1555 1555 1.35 LINK C PTR A 577 N SER A 578 1555 1555 1.34 LINK C ASP A 646 N PTR A 647 1555 1555 1.35 LINK C PTR A 647 N PTR A 648 1555 1555 1.34 LINK C PTR A 648 N LYS A 649 1555 1555 1.34 CISPEP 1 ARG A 498 ALA A 499 0 -11.54 SITE 1 AC1 18 LEU A 478 GLY A 479 GLY A 481 VAL A 486 SITE 2 AC1 18 ALA A 506 LYS A 508 GLU A 525 MET A 529 SITE 3 AC1 18 ILE A 539 VAL A 555 GLU A 556 ALA A 558 SITE 4 AC1 18 GLY A 561 ASN A 622 LEU A 624 ALA A 634 SITE 5 AC1 18 ASP A 635 PHE A 636 CRYST1 48.143 61.225 59.645 90.00 112.98 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020771 0.000000 0.008810 0.00000 SCALE2 0.000000 0.016333 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018212 0.00000